JAMA Dermatology

JAMA Dermatology JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed publications.

Antibiotic use during immune checkpoint blockade was associated with higher risk of immune-related cutaneous adverse eve...
12/17/2025

Antibiotic use during immune checkpoint blockade was associated with higher risk of immune-related cutaneous adverse events ( ), including pruritus and maculopapular rash. https://ja.ma/4s2Kd4K

Monthly vixarelimab led to rapid and sustained improvement in pruritus and lesion severity for adults with , with no se...
12/17/2025

Monthly vixarelimab led to rapid and sustained improvement in pruritus and lesion severity for adults with , with no serious drug-related adverse events reported.

https://ja.ma/4rVFPV3

In this qualitative study, patient self-advocacy and access to Spanish-speaking clinicians facilitated quicker diagnos...
12/17/2025

In this qualitative study, patient self-advocacy and access to Spanish-speaking clinicians facilitated quicker diagnosis among Latino patients; health system challenges remain.

https://ja.ma/3W4zgkB

In a clinic-based survey, patients demonstrated variable understanding of skin cancer–related terminology, with only 64....
12/13/2025

In a clinic-based survey, patients demonstrated variable understanding of skin cancer–related terminology, with only 64.2% correctly identifying "clear margins" and 21.6% understanding "dysplastic nevus." https://ja.ma/4pwUbtl

A man in his 50s developed broad-spectrum abnormal localized photosensitivity syndrome, presenting as recurrent sun-indu...
12/12/2025

A man in his 50s developed broad-spectrum abnormal localized photosensitivity syndrome, presenting as recurrent sun-induced, site-specific erythematous plaques confirmed by targeted phototesting. https://ja.ma/4pvTiBg

Acne prevalence among transmasculine patients ranged from 29.6% to 61.9% depending on methodology, with incidence increa...
12/11/2025

Acne prevalence among transmasculine patients ranged from 29.6% to 61.9% depending on methodology, with incidence increasing at 6 to 12 months after initiating testosterone therapy.

📌 This scoping review aims to summarize current literature for prevalence and factors associated with acne in transmasculine patients.

https://ja.ma/452ZGYx

💬 Editor's Note: Botulinum toxin injections appear safe and highly effective for acute digital ischemia and ulcers, part...
12/10/2025

💬 Editor's Note: Botulinum toxin injections appear safe and highly effective for acute digital ischemia and ulcers, particularly in systemic sclerosis and autoimmune vasculopathies, with minimal adverse events reported.

https://ja.ma/3KRXjB1

Botulinum toxin injections were associated with high complete response rates for acute digital ischemia (93.1%), ischemi...
12/10/2025

Botulinum toxin injections were associated with high complete response rates for acute digital ischemia (93.1%), ischemic ulcers (90.1%), and gangrene (87.5%), with minimal adverse events.

https://ja.ma/4oGnB79

Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis affecting small- to medium-sized vessels via antineut...
12/08/2025

Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis affecting small- to medium-sized vessels via antineutrophil cytoplasmic antibodies directed against proteinase 3.

This case report describes 2 patients with seronegative GPA. https://ja.ma/4iCJyTe

Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis affecting small- to medium-sized vessels via antineut...
12/08/2025

Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis affecting small- to medium-sized vessels via antineutrophil cytoplasmic antibodies directed against proteinase 3.

This case report describes 2 patients with seronegative GPA. https://ja.ma/4iZzfJn

Substituting roflumilast for apremilast in psoriatic disease from 2014-2024 may have saved the US health system up to $1...
12/07/2025

Substituting roflumilast for apremilast in psoriatic disease from 2014-2024 may have saved the US health system up to $13.5 billion. https://ja.ma/4rV5xt0

Substituting roflumilast for apremilast in psoriatic disease from 2014-2024 may have saved the US health system up to $1...
12/07/2025

Substituting roflumilast for apremilast in psoriatic disease from 2014-2024 may have saved the US health system up to $13.5 billion. https://ja.ma/4plfjCO

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

(312) 670-7827

Website

Alerts

Be the first to know and let us send you an email when JAMA Dermatology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category